Latest Headlines

Unisound Releases U2: A Native Agentic Large Model Built for Execution, Capable of Autonomously Decomposing and Completing 100+ Steps in Complex Real-World Workflows
PR Newswire

PR Newswire

Unisound Releases U2: A Native Agentic Large Model Built for Execution, Capable of Autonomously Decomposing and Completing 100+ Steps in Complex Real-World Workflows

7 小时前

Vi Appoints Spencer Honeyman as President, Global Growth
PR Newswire

PR Newswire

Vi Appoints Spencer Honeyman as President, Global Growth

7 小时前

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39
PR Newswire

PR Newswire

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39

8 小时前

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
PR Newswire

PR Newswire

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

10 小时前

VolitionRx Announces Pricing of $4.6 Million Public Offering
PR Newswire

PR Newswire

VolitionRx Announces Pricing of $4.6 Million Public Offering

10 小时前

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
PR Newswire

PR Newswire

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

11 小时前

CERAVE VÍTA NA PRVÝCH GLOBÁLNYCH CENÁCH CERAWARDS VIAC AKO 100 OCENENÝCH TVORCOV OBSAHU Z 22 KRAJÍN
PR Newswire

PR Newswire

CERAVE VÍTA NA PRVÝCH GLOBÁLNYCH CENÁCH CERAWARDS VIAC AKO 100 OCENENÝCH TVORCOV OBSAHU Z 22 KRAJÍN

12 小时前

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
PR Newswire

PR Newswire

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

12 小时前

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
PR Newswire

PR Newswire

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

13 小时前

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
PR Newswire

PR Newswire

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

13 小时前